Civic Intelligence

The Gerson Research Organization

990EZ • Fiscal year 2018 • EIN 33-0588751

Jan 01, 2018 to Dec 31, 2018 • Filed on Nov 18, 2019

Organization ProfileN/A
7807 Artesian RoadSan Diego, CA 92127

(858) 774-6642

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

96th percentile

1.51x

Higher debt load relative to assets than 96% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

82nd percentile

0.09x

Higher debt load relative to revenue than 82% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Net Margin

34th percentile

-2.9%

Higher net margin than 34% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Top Officer Pay

97th percentile

$78,268

Higher top officer pay than 97% of similar nonprofits.

Top officer pay equals 51.8% of source-year revenue.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Asset Growth

14th percentile

-33%

Faster asset growth than 14% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Revenue Growth

83rd percentile

42%

Faster revenue growth than 83% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Balance Sheet
Liabilities / Assets96th percentile

Assets

Down

$8,846

Down $4,409 (-33%) from 2017

Net Assets

Down

-$4,543

Down $4,409 (-3290%) from 2017

Liabilities

Flat

$13,389

Flat from 2017

Revenue And Expenses
Liabilities / Revenue82nd percentileNet Margin34th percentile

Revenue

Up

$150,951

Up $44,576 (+42%) from 2017

Expenses

Up

$155,360

Up $67,180 (+76%) from 2017

Net Income

Down

-$4,409

Down $22,604 (-124%) from 2017

Historical Trend

Balance Sheet Trend

Asset Growth14th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2013: $2,293Liabilities 2013: $12,965Net Assets 2013: -$10,6722013Assets 2014: $35,526Liabilities 2014: $12,965Net Assets 2014: $22,5612014Assets 2015: $19,345Liabilities 2015: $12,965Net Assets 2015: $6,3802015Assets 2016: $2,135Liabilities 2016: $20,464Net Assets 2016: -$18,3292016Assets 2017: $13,255Liabilities 2017: $13,389Net Assets 2017: -$1342017Assets 2018: $8,846Liabilities 2018: $13,389Net Assets 2018: -$4,5432018Assets 2019: $4,785Liabilities 2019: $13,389Net Assets 2019: -$8,6042019Assets 2020: $2,915Liabilities 2020: $13,389Net Assets 2020: -$10,4742020Assets 2021: $11,995Liabilities 2021: $21,796Net Assets 2021: -$9,8012021Assets 2022: $70,401Liabilities 2022: $0Net Assets 2022: $70,4012022Assets 2023: $61,959Liabilities 2023: $0Net Assets 2023: $61,9592023Assets 2024: $74,172Liabilities 2024: $0Net Assets 2024: $74,1722024

Highlighted filing

2018

Assets$8,846
Liabilities$13,389
Net Assets-$4,543
Open 2018 Filing

Operations Trend

Revenue Growth83rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100KRevenue 2013: $50,420Expenses 2013: $50,917Net Income 2013: -$4972013Revenue 2014: $88,448Expenses 2014: $55,215Net Income 2014: $33,2332014Revenue 2015: $62,746Expenses 2015: $78,927Net Income 2015: -$16,1812015Revenue 2016: $69,437Expenses 2016: $94,146Net Income 2016: -$24,7092016Revenue 2017: $106,375Expenses 2017: $88,180Net Income 2017: $18,1952017Revenue 2018: $150,951Expenses 2018: $155,360Net Income 2018: -$4,4092018Revenue 2019: $100,450Expenses 2019: $104,511Net Income 2019: -$4,0612019Revenue 2020: $37,778Expenses 2020: $39,648Net Income 2020: -$1,8702020Revenue 2021: $31,688Expenses 2021: $31,015Net Income 2021: $6732021Revenue 2022: $215,926Expenses 2022: $135,724Net Income 2022: $80,2022022Revenue 2023: $38,186Expenses 2023: $46,628Net Income 2023: -$8,4422023Revenue 2024: $60,158Expenses 2024: $47,945Net Income 2024: $12,2132024

Highlighted filing

2018

Revenue$150,951
Expenses$155,360
Net Income-$4,409
Open 2018 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Signed
Nov 18, 2019
Return Version
2018v3.1
Gross Receipts
$150,951
Mission and Program Overview

Mission

Research cancer treatment outcome

Program Services

DescriptionGrantsExpenses
The Gerson Research Organization provided substantial epidemiological services in 2018 to the CHIPSA Hospital, the Gerson Institute, and Batu Biologics. Forty-year retrospective melanoma survival study in process with Gerson Institute started analysis using JMP/SAS (program license provided by Gerson Institute).Identified and recruited 22 scientifically-validated advanced-cancer patients who are long-term survivors for the CHIPSA-anchored motion picture, A Celebration of Life (now in post-production).Systematic review of the oeuvre of Max Gerson with attention to ancillary literature in preparation for implementation at CHIPSA. Continuing translation of Diet Therapy of Pulmonary Tuberculosis by Max Gerson (525 of 619 pages completed to date). Introduced to CHIPSA owners the concept of using Gersons classic academic tuberculosis monograph as the textbook of clinical principles and practice for the Gerson diet at CHIPSA.Advanced methodology with St Andrews Clinic physicians and nurses; taught the Danger Model of Matzinger and Fuchs in the context of tumor immunotherapy; implemented tuberculosis-diet principles as articulated by Gerson in his book My Diet. Continued patient education/informed consent.Continued creation of a data-trapping system and basic tumor registry functions within CHIPSA. Created patient-education video lecture series on methods and materials of CHIPSA: https://www.facebook.com/chipsahospital/videos/1971748283110388/.Coordinated data collection for FDA/Ex-US/Phase 1 clinical trial of ValloVax (Batu Biologics). Established infrastructure for health information management/cancer information management (HIM/CIM) and dovetailed this with the above CHIPSA data-trapping system and tumor-registry functions. Presented early outcomes.$152,289-
Compensation and Service Providers
Top Officer Pay97th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
GAR HILDENBRANDPres/Exec DirectorFT$66,000$12,268$78,268
CHRISTEENE HILDENBRANDV.P./DirectorFT$24,000-$24,000
KAREN COOKDirector-$0--
DANIELLE MICHAEL JAMESDirector-$0--
JOHN PATRICK MARTINDirector-$0--
Filing and Contact Details

Filer

Filer Name
Gerson Research Organization
EIN
33-0588751
Phone
8587746642
Address
7807 ARTESIAN ROAD, SAN DIEGO, CA 92127

Signing Officer

Name
Gar Hildenbrand
Title
President
Signed
2019-11-18
Discuss with paid preparer
Yes

Preparer

Firm
Benito & Company
Address
10801 Thornmint Road Suite 150, San Diego, CA 92127
Preparer
Mark Benito CPA
Phone
8584870777
Supplemental Narrative

Additional Explanations

Other Expenses.1002

“Office Expenses $4246”

Other Expenses.1005

“Travel $6502”

Other Expenses.1

“Education & research $22394”

Other Expenses.2

“TELEPHONE $5352”

Other Expenses.4

“TRANSLATION $156”

Other Expenses.5

“REPAIRS $91”

Other Expenses.6

“BANK CHARGES $87”

Total Liabilities.1006

“Payable to Officers, Directors, Etc. - Beginning $13389 Payable to Officers, Directors, Etc. - Ending $13389”

Raw XML Appendix153 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CHRISTEENE HILDENBRAND
IRS990EZ/BooksInCareOfDetail/PhoneNum08587746642
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt07807 ARTESIAN ROAD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092127
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt013255
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt08846
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0128451
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-4409
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02220
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form720FiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt013255
IRS990EZ/Form990TotalAssetsGrp/EOYAmt08846
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt0150951
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/LoansToFromOfficersAmt013389
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0true
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0-134
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0-4543
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0-134
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0-4543
IRS990EZ/OccupancyRentUtltsAndMaintAmt02926
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt070.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt170.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt066000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt124000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt012268
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0GAR HILDENBRAND
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1CHRISTEENE HILDENBRAND
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2KAREN COOK
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DANIELLE MICHAEL JAMES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4JOHN PATRICK MARTIN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRES/EXEC DIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1V.P./DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationFiled990TInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt038828
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0RESEARCH CANCER TREATMENT OUTCOME
IRS990EZ/PrintingPublicationsPostageAmt01687
IRS990EZ/ProgramServiceRevenueAmt022500
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0The Gerson Research Organization provided substantial epidemiological services in 2018 to the CHIPSA Hospital, the Gerson Institute, and Batu Biologics. Forty-year retrospective melanoma survival study in process with Gerson Institute started analysis using JMP/SAS (program license provided by Gerson Institute).Identified and recruited 22 scientifically-validated advanced-cancer patients who are long-term survivors for the CHIPSA-anchored motion picture, A Celebration of Life (now in post-production).Systematic review of the oeuvre of Max Gerson with attention to ancillary literature in preparation for implementation at CHIPSA. Continuing translation of Diet Therapy of Pulmonary Tuberculosis by Max Gerson (525 of 619 pages completed to date). Introduced to CHIPSA owners the concept of using Gersons classic academic tuberculosis monograph as the textbook of clinical principles and practice for the Gerson diet at CHIPSA.Advanced methodology with St Andrews Clinic physicians and nurses; taught the Danger Model of Matzinger and Fuchs in the context of tumor immunotherapy; implemented tuberculosis-diet principles as articulated by Gerson in his book My Diet. Continued patient education/informed consent.Continued creation of a data-trapping system and basic tumor registry functions within CHIPSA. Created patient-education video lecture series on methods and materials of CHIPSA: https://www.facebook.com/chipsahospital/videos/1971748283110388/.Coordinated data collection for FDA/Ex-US/Phase 1 clinical trial of ValloVax (Batu Biologics). Established infrastructure for health information management/cancer information management (HIM/CIM) and dovetailed this with the above CHIPSA data-trapping system and tumor-registry functions. Presented early outcomes.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt0152289
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/RelatedOrgSect527OrgInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt0109699
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt013389
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt013389
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0155360
IRS990EZ/TotalProgramServiceExpensesAmt0152289
IRS990EZ/TotalRevenueAmt0150951
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/HospitalInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt013389
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0ADVANCE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt020464
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0GAR HILDENBRAND
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0PRESIDEN
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0false
IRS990ScheduleL/TotalBalanceDueAmt013389
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Office Expenses $4246
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Travel $6502
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2EDUCATION & RESEARCH $22394
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3TELEPHONE $5352
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4TRANSLATION $156
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5REPAIRS $91
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6BANK CHARGES $87
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7Payable to Officers, Directors, Etc. - Beginning $13389 Payable to Officers, Directors, Etc. - Ending $13389
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.5
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Total Liabilities.1006
ReturnHeader/BuildTS02020-04-17 16:48:07Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0GAR HILDENBRAND
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02019-11-18
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0GERSON RESEARCH ORGANIZATION
ReturnHeader/Filer/BusinessNameControlTxt0GERS
ReturnHeader/Filer/EIN0330588751
ReturnHeader/Filer/PhoneNum08587746642
ReturnHeader/Filer/USAddress/AddressLine1Txt07807 ARTESIAN ROAD
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092127
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330739062
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Benito & Company
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt010801 Thornmint Road Suite 150
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0San Diego
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092127
ReturnHeader/PreparerPersonGrp/PhoneNum08584870777
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MARK BENITO CPA
ReturnHeader/ReturnTs02019-11-18T09:12:39-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02018-01-01
ReturnHeader/TaxPeriodEndDt02018-12-31
ReturnHeader/TaxYr02018

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2018 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$8,846
Liabilities
$13,389
Net assets
-$4,543
Revenue
$150,951
Expenses
$155,360
Net income
-$4,409
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.74$0.00$0.74$0.60$0.48$0.12
2023Detailed filing. Detailed filing data is available for this year.$0.62$0.00$0.62$0.38$0.47$0.08
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.70$0.00$0.70$2.16$1.36$0.80
2021Detailed filing. Detailed filing data is available for this year.$0.12$0.22$0.10$0.32$0.31$0.01
2020Detailed filing. Detailed filing data is available for this year.$0.03$0.13$0.10$0.38$0.40$0.02
2019Detailed filing. Detailed filing data is available for this year.$0.05$0.13$0.09$1.00$1.05$0.04
2018Detailed filing. Detailed filing data is available for this year.$0.09$0.13$0.05$1.51$1.55$0.04
2017Detailed filing. Detailed filing data is available for this year.$0.13$0.13$0.00$1.06$0.88$0.18
2016Detailed filing. Detailed filing data is available for this year.$0.02$0.20$0.18$0.69$0.94$0.25
2015Detailed filing. Detailed filing data is available for this year.$0.19$0.13$0.06$0.63$0.79$0.16
2014Detailed filing. Detailed filing data is available for this year.$0.36$0.13$0.23$0.88$0.55$0.33
2013Detailed filing. Detailed filing data is available for this year.$0.02$0.13$0.11$0.50$0.51$0.00